# Vitamin D and Type 2 Diabetes - Treat-To-Target

> **NCT07448974** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Tufts Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Prediabetes
- Type 2 Diabetes (T2DM)

## Interventions

- **DRUG:** Vitamin D (Cholecalciferol )
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07448974
- **Lead sponsor:** Tufts Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2030-03
- **Final completion:** 2031-03
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07448974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07448974, "Vitamin D and Type 2 Diabetes - Treat-To-Target". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07448974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*